Effect of Helmet Noninvasive Ventilation vs Usual Respiratory Support on Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19

医学 2019年冠状病毒病(COVID-19) 急性呼吸衰竭 机械通风 严重急性呼吸综合征冠状病毒2型(SARS-CoV-2) 呼吸衰竭 2019-20冠状病毒爆发 重症监护医学 急诊医学 通风(建筑) 呼吸系统 内科学 病毒学 传染病(医学专业) 疾病 工程类 爆发 机械工程
作者
Yaseen M. Arabi,Sara Aldekhyl,Saad Al Qahtani,Hasan M. Al‐Dorzi,Sheryl Ann Abdukahil,Mohammed K. Al Harbi,Eman Al Qasim,Ayman Kharaba,Talal Albrahim,Mohammed Alshahrani,Abdulrahman Al‐Fares,Ali Al Bshabshe,Ahmed Mady,Zainab Al Duhailib,Haifa Algethamy,Jesna Jose,Mohammed Al Mutairi,Omar Al Zumai,Hussain Al Haji,Ahmed Alaqeily
出处
期刊:JAMA [American Medical Association]
卷期号:328 (11): 1063-1063 被引量:45
标识
DOI:10.1001/jama.2022.15599
摘要

Importance Helmet noninvasive ventilation has been used in patients with COVID-19 with the premise that helmet interface is more effective than mask interface in delivering prolonged treatments with high positive airway pressure, but data about its effectiveness are limited. Objective To evaluate whether helmet noninvasive ventilation compared with usual respiratory support reduces mortality in patients with acute hypoxemic respiratory failure due to COVID-19 pneumonia. Design, Setting, and Participants This was a multicenter, pragmatic, randomized clinical trial that was conducted in 8 sites in Saudi Arabia and Kuwait between February 8, 2021, and November 16, 2021. Adult patients with acute hypoxemic respiratory failure (n = 320) due to suspected or confirmed COVID-19 were included. The final follow-up date for the primary outcome was December 14, 2021. Interventions Patients were randomized to receive helmet noninvasive ventilation (n = 159) or usual respiratory support (n = 161), which included mask noninvasive ventilation, high-flow nasal oxygen, and standard oxygen. Main Outcomes and Measures The primary outcome was 28-day all-cause mortality. There were 12 prespecified secondary outcomes, including endotracheal intubation, barotrauma, skin pressure injury, and serious adverse events. Results Among 322 patients who were randomized, 320 were included in the primary analysis, all of whom completed the trial. Median age was 58 years, and 187 were men (58.4%). Within 28 days, 43 of 159 patients (27.0%) died in the helmet noninvasive ventilation group compared with 42 of 161 (26.1%) in the usual respiratory support group (risk difference, 1.0% [95% CI, −8.7% to 10.6%]; relative risk, 1.04 [95% CI, 0.72-1.49]; P = .85). Within 28 days, 75 of 159 patients (47.2%) required endotracheal intubation in the helmet noninvasive ventilation group compared with 81 of 161 (50.3%) in the usual respiratory support group (risk difference, −3.1% [95% CI, −14.1% to 7.8%]; relative risk, 0.94 [95% CI, 0.75-1.17]). There were no significant differences between the 2 groups in any of the prespecified secondary end points. Barotrauma occurred in 30 of 159 patients (18.9%) in the helmet noninvasive ventilation group and 25 of 161 (15.5%) in the usual respiratory support group. Skin pressure injury occurred in 5 of 159 patients (3.1%) in the helmet noninvasive ventilation group and 10 of 161 (6.2%) in the usual respiratory support group. There were 2 serious adverse events in the helmet noninvasive ventilation group and 1 in the usual respiratory support group. Conclusions and Relevance Results of this study suggest that helmet noninvasive ventilation did not significantly reduce 28-day mortality compared with usual respiratory support among patients with acute hypoxemic respiratory failure due to COVID-19 pneumonia. However, interpretation of the findings is limited by imprecision in the effect estimate, which does not exclude potentially clinically important benefit or harm. Trial Registration ClinicalTrials.gov Identifier: NCT04477668
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lc完成签到,获得积分10
2秒前
5秒前
李健的小迷弟应助anna采纳,获得10
6秒前
量子星尘发布了新的文献求助10
6秒前
8秒前
8秒前
嘀嘀咕咕发布了新的文献求助10
8秒前
大观天下完成签到,获得积分10
8秒前
科研通AI2S应助科研通管家采纳,获得10
9秒前
英姑应助科研通管家采纳,获得10
9秒前
科研通AI5应助科研通管家采纳,获得10
9秒前
9秒前
科研通AI2S应助科研通管家采纳,获得10
9秒前
共享精神应助科研通管家采纳,获得10
9秒前
科目三应助科研通管家采纳,获得10
9秒前
bkagyin应助科研通管家采纳,获得10
9秒前
SciGPT应助科研通管家采纳,获得10
9秒前
CodeCraft应助科研通管家采纳,获得10
9秒前
orixero应助科研通管家采纳,获得10
10秒前
脑洞疼应助科研通管家采纳,获得10
10秒前
10秒前
兴奋千兰发布了新的文献求助10
11秒前
有机发布了新的文献求助10
12秒前
yukang发布了新的文献求助10
12秒前
14秒前
大观天下发布了新的文献求助30
15秒前
15秒前
17秒前
18秒前
小盘子完成签到,获得积分10
18秒前
19秒前
今后应助务实的大神采纳,获得10
19秒前
anna发布了新的文献求助10
22秒前
22秒前
Elaine完成签到,获得积分10
22秒前
24秒前
nolan完成签到 ,获得积分10
24秒前
26秒前
彭于晏应助嘀嘀咕咕采纳,获得10
26秒前
搜集达人应助感动的山槐采纳,获得10
27秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989069
求助须知:如何正确求助?哪些是违规求助? 3531351
关于积分的说明 11253589
捐赠科研通 3269939
什么是DOI,文献DOI怎么找? 1804851
邀请新用户注册赠送积分活动 882074
科研通“疑难数据库(出版商)”最低求助积分说明 809073